Tanzisertib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTanzisertib
Drug Alias Nametanzisertibum坦齐色替坦齐舍替CC-930JNK-CC-930 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsFibrosisLupus Erythematosus, DiscoidIdiopathic Pulmonary Fibrosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals IncCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsFibrosisLupus Erythematosus, DiscoidIdiopathic Pulmonary Fibrosis +[5] 

Other Information

ATC CodeN/A
Related LinksKEGG